CALMODULIN INHIBITOR TRIFLUOPERAZINE SELECTIVELY ENHANCES CYTO-TOXIC EFFECTS OF STRONG VS WEAK DNA-BINDING ANTITUMOR DRUGS IN DOXORUBICIN-RESISTANT P388 MOUSE LEUKEMIA-CELLS

被引：16

作者：

GANAPATHI, R ^{[1
]}

GRABOWSKI, D ^{[1
]}

SCHMIDT, H ^{[1
]}

SESHADRI, R ^{[1
]}

ISRAEL, M ^{[1
]}

机构：

[1] UNIV TENNESSEE,CTR HLTH SCI,MEMPHIS,TN 38163

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1985年 / 131卷 / 02期

关键词：

D O I：

10.1016/0006-291X(85)91326-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：912 / 919

页数：8

共 14 条

[1] ADRIAMYCIN - REVIEW [J].

CARTER, SK .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) :1265-1274

[2]

CENTER MS, 1985, BIOCHEM PHARMACOL, V34, P1471, DOI 10.1016/0006-2952(85)90686-0

[3]

DANO K, 1976, ACTA PATHOL MICRA SN, V256, P11

[4] CORRELATION BETWEEN POTENCY OF CALMODULIN INHIBITORS AND EFFECTS ON CELLULAR-LEVELS AND CYTO-TOXIC ACTIVITY OF DOXORUBICIN (ADRIAMYCIN) IN RESISTANT P388 MOUSE LEUKEMIA-CELLS [J].

GANAPATHI, R ;

GRABOWSKI, D ;

TURINIC, R ;

VALENZUELA, R .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06) :799-806

[5]

GANAPATHI R, 1983, CANCER RES, V43, P3696

[6]

GANAPATHI R, 1984, CANCER RES, V44, P5056

[7]

INABA M, 1979, CANCER RES, V39, P2200

[8]

ISRAEL M, 1985, P AM ASSOC CANC RES, V26, P220

[9]

ISRAEL M, 1985, 189TH NAT M AM CHEM

[10]

JOHNSON RK, 1978, CANCER TREAT REP, V62, P1535

← 1 2 →